FeesSafety
Pluang+

Analyst raises Alector price target to $8 on neurodegenerative drug progress and Genentech deal

Analyst Insights
14 Oct 2026, 23:12 WIB
Tony Dante
View Source
Bullish
Analyst raises Alector price target to $8 on neurodegenerative drug progress and Genentech deal

H.C. Wainwright raised its price target for Alector from $5.00 to $8.00, maintaining a Buy rating due to progress in its neurodegenerative disease pipeline. Alector develops treatments for Alzheimer's and Parkinson's using its Brain Carrier platform to deliver drugs across the blood-brain barrier. The company secured a $100 million upfront payment from a licensing deal with Genentech, extending its financial runway to 2029. This deal could bring up to $1.17 billion in milestones plus royalties, supporting Alector's shift toward bispecific antibodies and nucleic acid therapies.

Alector's price target was recently raised to $8. For readers following the health sector, here is Pluang's market snapshot as of Oct 14, 2026 23:21 WIB: out of 150 US health stocks, 78 rose and 71 fell. Among notable movers, Eli Lilly And Co (LLY) gained 4.08% to USD 1,214.15 with a typical hold time of 94 days, contrasting with Teladoc Health Inc (TDOC) and ClearPoint Neuro Inc (CLPT), which both declined over 4%, priced at USD 5.73 and USD 9.39 respectively, with CLPT seeing 100% buy order activity but a much shorter hold time of 10 days.

More News

PBF Energy cuts net debt by $1.2B, boosts dividend 18%, and expects $130M interest savings in 2027

PBF Energy cuts net debt by $1.2B, boosts dividend 18%, and expects $130M interest savings in 2027

PBF Energy reduced its net debt by over $1.2 billion in Q3 2026, part of a broader effort that has cut more than $2 billion in net debt this year. This debt reduction is expected to lower interest expenses by $130 million in 2027, improving financial...

Company Fundamentals
Bullish
1 hour ago
Railcar scrapping outpaces production in 2026, boosting lease prices and fleet investment at Trinity Industries.

Railcar scrapping outpaces production in 2026, boosting lease prices and fleet investment at Trinity Industries.

In 2026, railcar scrapping in North America is expected to reach 40,000 units, surpassing new railcar production and tightening market supply. Trinity Industries has already met its three-year net fleet investment target ahead of schedule, highlighti...

Company Fundamentals
Bullish
1 hour ago
TMD Energy files annual report with audited financials for fiscal year ending June 2026

TMD Energy files annual report with audited financials for fiscal year ending June 2026

TMD Energy Limited has filed its annual report on Form 20-F with the SEC, including audited consolidated financial statements for the fiscal year ended June 30, 2026. The report is accessible online and hard copies are available free to shareholders ...

Company Fundamentals
Neutral
1 hour ago
Dividend Kings Abbott, McDonald's, and Tennant offer buying opportunities amid recent pullbacks and strategic moves.

Dividend Kings Abbott, McDonald's, and Tennant offer buying opportunities amid recent pullbacks and strategic moves.

Abbott Laboratories, McDonald's, and Tennant, all Dividend Kings with over 50 years of consecutive dividend increases, have recently seen their stock prices dip, presenting buying opportunities. Abbott plans to spin off its struggling nutrition divis...

Company Fundamentals
Bullish
1 hour ago
Extra Space Storage raises 2026 earnings forecast on strong revenue growth and cost cuts

Extra Space Storage raises 2026 earnings forecast on strong revenue growth and cost cuts

Extra Space Storage raised its full-year 2026 earnings guidance after reporting strong third-quarter results, including $2.17 per share in core funds from operations and 2.7% same-store revenue growth across 27 top markets. The company credited impro...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App